Welcome to the Patent Panorama Blog No results found Lisa Mueller 8/1/26 Lisa Mueller 8/1/26 Salts, Ratios, and Security: Federal Circuit Affirms Nuedexta Preliminary Injunction but Vacates Bond Waiver in Otsuka v. Hetero Read More Lisa Mueller 7/27/26 Lisa Mueller 7/27/26 Projected Doses Were Not Enough: Federal Circuit Affirms Lack of Enablement in Wyeth v. AstraZeneca Read More Lisa Mueller 7/22/26 Lisa Mueller 7/22/26 The Fair Seeds for Farmers Act: Congress Takes Aim at Utility Patents and Seed-Use Restrictions Read More Lisa Mueller 7/2/26 Lisa Mueller 7/2/26 Small Forms, Big Consequences: FDA’s Draft Q&A on Orange Book Patent Forms 3542 and 3542a Read More Lisa Mueller 6/28/26 Lisa Mueller 6/28/26 Operation TrialBlazer: HHS Bets on Speed to Keep Early-Stage Innovation (and Its IP) at Home Read More Lisa Mueller 6/26/26 Lisa Mueller 6/26/26 When "2" Cannot Mean "1": The Federal Circuit Holds Enanta to the Exact Words of Its Provisional in the Paxlovid Patent Fight Read More Lisa Mueller 6/24/26 Lisa Mueller 6/24/26 The Clock Tightens: USPTO Cuts the “Unintentional Delay” Threshold from Two Years to One Read More Lisa Mueller 6/6/26 Lisa Mueller 6/6/26 Inside a PIER Requirement: A Practitioner’s Guide to the USPTO’s PCT Informed Examination Request Pilot Read More Lisa Mueller 5/1/26 Lisa Mueller 5/1/26 Brazil Tightens the Screws on Technology Transfer Pricing in Productive Development Partnerships: What the Ministry of Health's New Methodology Means for IP Holders Read More Lisa Mueller 4/8/26 Lisa Mueller 4/8/26 A New Era for Mexican Patent Law: Mexico Publishes Sweeping Amendments to the Federal Law for the Protection of Industrial Property Read More Lisa Mueller 4/3/26 Lisa Mueller 4/3/26 When a Missing Coinventor Cannot Be Found: Federal Circuit Affirms Invalidity of Patents for Omission of an Unreachable Inventor in Fortress Iron, LP v. Digger Specialties, Inc. Read More Lisa Mueller 3/26/26 Lisa Mueller 3/26/26 Indonesia’s New Patent Application Regulation: Tighter Filing Requirements, Accelerated Examination, and a Formal Repeat Examination Mechanism Read More Lisa Mueller 3/20/26 Lisa Mueller 3/20/26 Update: Argentina Repeals Restrictive Pharmaceutical Patentability Guidelines — Joint Resolution 1/2026 Published on March 18, 2026 Read More Lisa Mueller 3/16/26 Lisa Mueller 3/16/26 Claim Construction and the Lexicographer’s Trap: Federal Circuit’s Narrow “Branched Alkyl” Construction in Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. Read More Lisa Mueller 3/13/26 Lisa Mueller 3/13/26 Argentina's Seismic IP Shift: The U.S.–Argentina Agreement on Reciprocal Trade and Investment Reshapes Patent Strategy for Pharma, Biotech, and Beyond Read More Lisa Mueller 2/25/26 Lisa Mueller 2/25/26 Genetically Engineered Host Cells Are Not "Nature's Handiwork": The Federal Circuit Breathes New Life into Biotech Patent Eligibility in REGENXBIO Inc. v. Sarepta Therapeutics, Inc. Read More Lisa Mueller 2/18/26 Lisa Mueller 2/18/26 Federal Circuit Reverses Jury Verdict: Allergan's Latisse Patent Claims Invalid for Lack of Written Description in Duke University v. Sandoz Inc. Read More Lisa Mueller 12/31/25 Lisa Mueller 12/31/25 China Backs Off Foreign Inventor ID Requirement: What U.S. Applicants Need to Know for 2026 Filings Read More Lisa Mueller 12/5/25 Lisa Mueller 12/5/25 Strategic Deployment of Third-Party Pre-Grant Submissions in Brazil's Patent Examination: A Comprehensive Guide for Life Sciences Practitioners Read More Lisa Mueller 11/24/25 Lisa Mueller 11/24/25 Seismic Shifts at the USPTO: Navigating Patent Practice in a New Era Read More Older Posts
Lisa Mueller 8/1/26 Lisa Mueller 8/1/26 Salts, Ratios, and Security: Federal Circuit Affirms Nuedexta Preliminary Injunction but Vacates Bond Waiver in Otsuka v. Hetero Read More
Lisa Mueller 7/27/26 Lisa Mueller 7/27/26 Projected Doses Were Not Enough: Federal Circuit Affirms Lack of Enablement in Wyeth v. AstraZeneca Read More
Lisa Mueller 7/22/26 Lisa Mueller 7/22/26 The Fair Seeds for Farmers Act: Congress Takes Aim at Utility Patents and Seed-Use Restrictions Read More
Lisa Mueller 7/2/26 Lisa Mueller 7/2/26 Small Forms, Big Consequences: FDA’s Draft Q&A on Orange Book Patent Forms 3542 and 3542a Read More
Lisa Mueller 6/28/26 Lisa Mueller 6/28/26 Operation TrialBlazer: HHS Bets on Speed to Keep Early-Stage Innovation (and Its IP) at Home Read More
Lisa Mueller 6/26/26 Lisa Mueller 6/26/26 When "2" Cannot Mean "1": The Federal Circuit Holds Enanta to the Exact Words of Its Provisional in the Paxlovid Patent Fight Read More
Lisa Mueller 6/24/26 Lisa Mueller 6/24/26 The Clock Tightens: USPTO Cuts the “Unintentional Delay” Threshold from Two Years to One Read More
Lisa Mueller 6/6/26 Lisa Mueller 6/6/26 Inside a PIER Requirement: A Practitioner’s Guide to the USPTO’s PCT Informed Examination Request Pilot Read More
Lisa Mueller 5/1/26 Lisa Mueller 5/1/26 Brazil Tightens the Screws on Technology Transfer Pricing in Productive Development Partnerships: What the Ministry of Health's New Methodology Means for IP Holders Read More
Lisa Mueller 4/8/26 Lisa Mueller 4/8/26 A New Era for Mexican Patent Law: Mexico Publishes Sweeping Amendments to the Federal Law for the Protection of Industrial Property Read More
Lisa Mueller 4/3/26 Lisa Mueller 4/3/26 When a Missing Coinventor Cannot Be Found: Federal Circuit Affirms Invalidity of Patents for Omission of an Unreachable Inventor in Fortress Iron, LP v. Digger Specialties, Inc. Read More
Lisa Mueller 3/26/26 Lisa Mueller 3/26/26 Indonesia’s New Patent Application Regulation: Tighter Filing Requirements, Accelerated Examination, and a Formal Repeat Examination Mechanism Read More
Lisa Mueller 3/20/26 Lisa Mueller 3/20/26 Update: Argentina Repeals Restrictive Pharmaceutical Patentability Guidelines — Joint Resolution 1/2026 Published on March 18, 2026 Read More
Lisa Mueller 3/16/26 Lisa Mueller 3/16/26 Claim Construction and the Lexicographer’s Trap: Federal Circuit’s Narrow “Branched Alkyl” Construction in Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. Read More
Lisa Mueller 3/13/26 Lisa Mueller 3/13/26 Argentina's Seismic IP Shift: The U.S.–Argentina Agreement on Reciprocal Trade and Investment Reshapes Patent Strategy for Pharma, Biotech, and Beyond Read More
Lisa Mueller 2/25/26 Lisa Mueller 2/25/26 Genetically Engineered Host Cells Are Not "Nature's Handiwork": The Federal Circuit Breathes New Life into Biotech Patent Eligibility in REGENXBIO Inc. v. Sarepta Therapeutics, Inc. Read More
Lisa Mueller 2/18/26 Lisa Mueller 2/18/26 Federal Circuit Reverses Jury Verdict: Allergan's Latisse Patent Claims Invalid for Lack of Written Description in Duke University v. Sandoz Inc. Read More
Lisa Mueller 12/31/25 Lisa Mueller 12/31/25 China Backs Off Foreign Inventor ID Requirement: What U.S. Applicants Need to Know for 2026 Filings Read More
Lisa Mueller 12/5/25 Lisa Mueller 12/5/25 Strategic Deployment of Third-Party Pre-Grant Submissions in Brazil's Patent Examination: A Comprehensive Guide for Life Sciences Practitioners Read More
Lisa Mueller 11/24/25 Lisa Mueller 11/24/25 Seismic Shifts at the USPTO: Navigating Patent Practice in a New Era Read More
